These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30473961)

  • 21. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.
    Young TN; Arens FJ; Kennedy GE; Laurie JW; Rutherford Gw
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002835. PubMed ID: 17253483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois.
    Huo D; Ouellet LJ
    Sex Transm Dis; 2009 Jan; 36(1):35-40. PubMed ID: 19008775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
    Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis.
    Shrestha S; Smith MW; Broman KW; Farzadegan H; Vlahov D; Strathdee SA
    J Acquir Immune Defic Syndr; 2006 Nov; 43(3):335-43. PubMed ID: 16980914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
    Xia X; Luo J; Bai J; Yu R
    Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons learned from a peri-urban needle exchange.
    Knittel AK; Wren PA; Gore L
    Harm Reduct J; 2010 Apr; 7():8. PubMed ID: 20429944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico.
    Robles RR; Colón HM; Matos TD; Finlinson HA; Muñoz A; Marrero CA; García M; Reyes JC
    Health Policy; 1998 Sep; 45(3):209-20. PubMed ID: 10338952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
    Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Lifepoint": a case study in using social science community identification data to guide the implementation of a needle exchange program.
    Somlai AM; Kelly JA; Otto-Salaj L; Nelson D
    AIDS Educ Prev; 1999 Jun; 11(3):187-202. PubMed ID: 10407453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstacles to needle exchange participation in Rhode Island.
    Rich JD; Strong L; Towe CW; McKenzie M
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):396-400. PubMed ID: 10458620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program.
    Henderson LA; Vlahov D; Celentano DD; Strathdee SA
    J Acquir Immune Defic Syndr; 2003 Feb; 32(2):229-37. PubMed ID: 12571535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient allocation of resources to prevent HIV infection among injection drug users: the Prevention Point Philadelphia (PPP) needle exchange program.
    Harris ZK
    Health Econ; 2006 Feb; 15(2):147-58. PubMed ID: 16145716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study.
    Pezzotti P; Galai N; Vlahov D; Rezza G; Lyles CM; Astemborski J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):275-82. PubMed ID: 10077177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.
    MacGowan RJ; Sterk CE; Long A; Cheney R; Seeman M; Anderson JE
    Int J Epidemiol; 1998 Apr; 27(2):302-8. PubMed ID: 9602414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV transmission in Bangladesh: an analysis of IDU programme coverage.
    Reddy A; Hoque MM; Kelly R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S37-46. PubMed ID: 18207724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.